Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >

ALS and the crushing cost of care: How 4 Americans face the 'bankruptcy disease'

May 14, 2026

Biogen advances Alzheimer's drug to late-stage trial despite disappointing data

May 14, 2026

Trump's pharmaceutical tariffs could affect some drugmakers more than others

July 29, 2025

FDA taps biotech industry veteran as RFK Jr.'s top drug regulator

July 21, 2025

Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks

April 01, 2025

Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short

February 12, 2025

5 things to know before the stock market opens Monday

February 10, 2025

Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug

January 15, 2025

Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction

October 30, 2024

Wednesday's big stock stories: What’s likely to move the market in the next trading session

October 29, 2024

5 things to know before the stock market opens Monday

October 28, 2024

Thursday's big stock stories: What's likely to move the market in the next trading session

September 25, 2024

5 things to know before the stock market opens Monday

September 09, 2024

Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment

September 08, 2024

Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction

August 01, 2024

Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says

July 30, 2024

Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says

July 30, 2024

European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai

July 26, 2024

Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug

June 11, 2024

Cramer's Lightning Round: Bank of America is a buy

May 10, 2024

Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up

April 24, 2024

5 things to know before the stock market opens Monday

April 22, 2024

Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move

March 08, 2024

Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start

February 20, 2024

Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies

February 13, 2024

5 things to know before the stock market opens Monday

February 12, 2024

Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments

January 31, 2024

Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma

December 20, 2023

5 things to know before the stock market opens Monday

November 06, 2023

More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study

October 25, 2023

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.